Abstract
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.
All Keywords
【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, drug, severe acute respiratory syndrome Coronavirus, CRISPR, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, cellular pathway, whole-genome, 【제목키워드】 SARS-CoV-2,
【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, drug, severe acute respiratory syndrome Coronavirus, CRISPR, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, cellular pathway, whole-genome, 【제목키워드】 SARS-CoV-2,
{{{ 추상적인 }}}
중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 감염과 관련된 주요 세포 경로를 밝히기 위해 다닐로스키와 동료들은 CRISPR 기반 전체 게놈 스크리닝을 사용했습니다. 그들의 결과는 COVID-19와의 지속적인 싸움을 위해 새로운 또는 재배치된 약물을 제안할 수 있습니다.